JP2011507855A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507855A5
JP2011507855A5 JP2010539511A JP2010539511A JP2011507855A5 JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5 JP 2010539511 A JP2010539511 A JP 2010539511A JP 2010539511 A JP2010539511 A JP 2010539511A JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5
Authority
JP
Japan
Prior art keywords
connexin
composition
agent
polynucleotide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507855A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014019 external-priority patent/WO2009085268A2/en
Publication of JP2011507855A publication Critical patent/JP2011507855A/ja
Publication of JP2011507855A5 publication Critical patent/JP2011507855A5/ja
Pending legal-status Critical Current

Links

JP2010539511A 2007-12-21 2008-12-22 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 Pending JP2011507855A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US888807P 2007-12-21 2007-12-21
PCT/US2008/014019 WO2009085268A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014152828A Division JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Publications (2)

Publication Number Publication Date
JP2011507855A JP2011507855A (ja) 2011-03-10
JP2011507855A5 true JP2011507855A5 (enExample) 2013-04-25

Family

ID=40824953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539511A Pending JP2011507855A (ja) 2007-12-21 2008-12-22 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用
JP2014152828A Pending JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014152828A Pending JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20110245184A1 (enExample)
EP (1) EP2237796A2 (enExample)
JP (2) JP2011507855A (enExample)
AU (1) AU2008343839A1 (enExample)
CA (1) CA2710223A1 (enExample)
WO (1) WO2009085268A2 (enExample)
ZA (1) ZA201005215B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2766549T3 (es) 2005-02-03 2020-06-12 Coda Therapeutics Ltd Compuestos anticonexina 43 para el tratamiento de heridas crónicas
JP2011506447A (ja) * 2007-12-11 2011-03-03 コーダ セラピューティクス, インコーポレイテッド 損傷した創傷治癒組成物および治療
AU2008343841A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of inhibitors of connexin43 for treatment of fibrotic conditions
CA2866115C (en) 2012-03-01 2020-03-24 Firststring Research, Inc. Topical gels containing alpha connexin c-terminal (act) peptides
US9156896B2 (en) * 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
EP3116996A4 (en) * 2014-03-14 2018-01-10 Ocunexus Therapeutics, Inc. Treatment of resistant lesions
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
CN105566495B (zh) * 2016-01-27 2019-10-22 上海科技大学 一种特异性抑制连接蛋白26的全人抗体
CA3061738A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
JP2023546757A (ja) 2020-10-22 2023-11-07 シークエル・バイオ・インコーポレイテッド ペプチド製剤および眼科におけるその使用
JP6911993B1 (ja) * 2020-12-11 2021-07-28 東洋インキScホールディングス株式会社 抗菌性活性エネルギー線硬化型コーティング組成物、コーティング層、抗菌性部材、および物品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1146908E (pt) * 1999-01-27 2005-10-31 David Dr Becker Formulacoes que contem nucleotidos de anti-sentido para conexinas
EP1435925A2 (en) * 2001-10-17 2004-07-14 University of Wales College of Medicine Gap junctions and edhf
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
JP5243040B2 (ja) * 2004-12-21 2013-07-24 ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント 創傷治癒および組織再生を促進するための組成物および方法
ES2766549T3 (es) * 2005-02-03 2020-06-12 Coda Therapeutics Ltd Compuestos anticonexina 43 para el tratamiento de heridas crónicas
JP5960944B2 (ja) * 2006-11-15 2016-08-02 コーダ セラピューティクス, インコーポレイテッド 創傷治癒のための改善された方法および組成物
AU2008335717A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
JP2011506447A (ja) * 2007-12-11 2011-03-03 コーダ セラピューティクス, インコーポレイテッド 損傷した創傷治癒組成物および治療

Similar Documents

Publication Publication Date Title
JP2011507855A5 (enExample)
JP2011507861A5 (enExample)
JP2011507860A5 (enExample)
JP6918724B2 (ja) 急性骨髄性白血病(aml)のための新規併用治療
JP5185826B2 (ja) ウイルス性肝炎の処置
JP2011506447A5 (enExample)
JP2011508605A5 (enExample)
US9629895B2 (en) Method for prevention or treatment of intractable inflammatory bowel disease
JP2009522371A5 (enExample)
CA2730789A1 (en) Treatment of inflammatory bowel diseases with mammal beta defensins
JP2011256204A5 (enExample)
EA032767B1 (ru) Применение баклофена или его соли для лечения болезни шарко-мари-тусса (смт) и связанного с ней расстройства
EA024523B1 (ru) Фармацевтическая композиция для лечения болезни шарко-мари-тута и родственных с ней расстройств
MX2010013984A (es) Combinacion de pilocarpina y metimazol para tratar la enfermedad de charcot-marie-tooth y trastornos relacionados.
JP2018087228A (ja) がんのためのグルフォスファミド組み合わせ療法
JP2009544585A5 (enExample)
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
KR101628448B1 (ko) 암 치료에 사용하기 위한 베무라페닙 및 인터페론을 포함하는 병용 요법
JP2011507859A5 (enExample)
WO2023192916A2 (en) Rna comprising secretomes and methods of their use
EP2240195A1 (en) Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
AU782357B2 (en) Treatment of dyskinesia
US20130004459A1 (en) Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma
WO2016071431A9 (en) A combination for cancer therapy
US9173918B2 (en) Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide